Research in Brief
This article was originally published in The Gray Sheet
Executive Summary
Enrollment ends for Boston Sci’s latest Watchman trial; Edwards, MicroVention studies begin.
You may also be interested in...
Research In Brief
Data updates from HRS, SCAI meetings, and more.
New Products In Brief
Boston Scientific becomes the first with drug-eluting stents that are FDA-approved for use in patients experiencing a heart attack. More product news.
Left Atrial Appendage Closure Studies: FDA Offers Tips
The clinical path toward FDA approval of a left atrial appendage closure system for preventing stroke in atrial fibrillation patients has not been simple so far, informing the agency’s current expectations.